Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: patient's choice".

George Woody Douglas Bruce P Todd Korthuis Sumedha Chhatre Maureen Hillhouse Petra Jacobs James Sorensen Andrew J Saxon Sabrina Poole David Metzger Walter Ling

J Acquir Immune Defic Syndr

*Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA †Treatment Research Institute, Philadelphia, PA ‡Yale University School of Medicine, New Haven, CT §Oregon Health and Science University, Portland, OR ‖University of California, Los Angeles, Los Angeles, CA ¶University of California, San Francisco, San Francisco, CA #Veterans Affairs Puget Sound Health Care System, Seattle, WA.

Published: December 2014

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229390	PMC
http://dx.doi.org/10.1097/QAI.0000000000000344	DOI Listing

Publication Analysis

Top Keywords

authors' reply

reply "risk

"risk reduction

reduction buprenorphine-naloxone

buprenorphine-naloxone methadone

methadone patient's

patient's choice"

authors'

"risk

reduction

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!